Welch Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,956
Closed -$202K – 327
2026
Q2
$202K Buy
+1,956
New +$175K 0.01% 306
2023
Q4
– Sell
-2,926
Closed -$204K – 230
2023
Q3
$204K Sell
2,926
-982
-25% -$69.6K 0.01% 203
2023
Q2
$270K Sell
3,908
-6
-0.2% -$427 0.02% 165
2023
Q1
$291K Sell
3,914
-67
-2% -$5.62K 0.02% 156
2022
Q4
$371K Sell
3,981
-508
-11% -$49K 0.02% 137
2022
Q3
$428K Buy
4,489
+255
+6% +$25.2K 0.03% 108
2022
Q2
$392K Sell
4,234
-335
-7% -$32.7K 0.02% 119
2022
Q1
$462K Buy
4,569
+374
+9% +$39.3K 0.03% 122
2021
Q4
$433K Buy
4,195
+169
+4% +$15.6K 0.03% 133
2021
Q3
$342K Buy
4,026
+802
+25% +$67.2K 0.02% 134
2021
Q2
$269K Sell
3,224
-133
-4% -$10.9K 0.02% 149
2021
Q1
$253K Buy
+3,357
New +$245K 0.02% 158
2020
Q2
– Sell
-1,846
Closed -$110K – 139
2020
Q1
$110K Buy
+1,846
New +$123K 0.01% 149
2016
Q4
– Sell
-2,036
Closed -$181K – 139
2016
Q3
$181K Buy
2,036
+173
+9% +$16.3K 0.04% 93
2016
Q2
$178K Sell
1,863
-990
-35% -$98.7K 0.04% 83
2016
Q1
$296K Buy
+2,853
New +$277K 0.05% 81

Other funds holding CVS

Welch Group's CVS Position: Q3 2026 in Review

Welch Group sold out of CVS Health (CVS) in Q3 2026, closing a stake of 1,956 shares — an estimated $202K sold.

Welch Group first reported a position in CVS in Q1 2016 and held it in 16 quarters. The position peaked at $462K in Q1 2022. 1,122 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Welch Group reported no remaining CVS Health position as of Q3 2026 after selling out during the quarter.
  • Welch Group sold 1,956 CVS Health shares in Q3 2026, an estimated $202K.
  • Welch Group first reported a position in CVS Health in Q1 2016 and held it in 16 quarters.
  • Welch Group's CVS Health position peaked at $462K in Q1 2022.
  • 1,122 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Welch Group's 13F filing for Q3 2026, filed 29 Oct 2026.